title: Short-course chemotherapy for pulmonary tuberculosis. Points of interest.
abstract: A build-up of numbers of tuberculosis patients who default at an early stage from the ambulatory intensive short-course chemotherapy routinely practised in the Combined Health Scheme of the Divisional Council of the Cape is bringing to light the bactericidal power of a four-drug, rifampicin-containing regimen. Within the range of 40-80 daily doses, all is by no means lost if the patient defaults.
mesh_terms: D000328:Adult; D000553:Ambulatory Care; D002675:Child, Preschool; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage*; D011718:Pyrazinamide / Q000008:administration & dosage*; D012293:Rifampin / Q000008:administration & dosage*; D013307:Streptomycin / Q000008:administration & dosage*; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
chemical_list: D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin